Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 20006-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#20006-1-AP, RRID:AB_10733472
- Product name
- CD134/OX40 antibody
- Antibody type
- Polyclonal
- Description
- CD134/OX40 antibody (Cat. #20006-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: FC, WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Y chromosome-linked EIF1AY deletion drives sex differences in multiple myeloma.
Generation of novel human anti-OX-40 mAbs endowed with different biological properties as tools for cancer therapy.
Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular Carcinoma.
A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Feng Z, Bai J, Li Y, Li L, Zhang L
NPJ precision oncology 2026 Feb 14;10(1)
NPJ precision oncology 2026 Feb 14;10(1)
Generation of novel human anti-OX-40 mAbs endowed with different biological properties as tools for cancer therapy.
Rapuano Lembo R, Passariello M, Manna L, Froechlich G, Belardo M, Nicosia A, Sasso E, De Lorenzo C
Frontiers in immunology 2025;16:1644391
Frontiers in immunology 2025;16:1644391
Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular Carcinoma.
Zhou Y, Zhou X, Liu Q, Zhang Z, Zhang W, Ma J, Yang M, Yu J, Luo J, Yan Z
Disease markers 2022;2022:8973721
Disease markers 2022;2022:8973721
A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y, Feng Y, Yan F, Zhao Y, Zhao H, Guo Y
Frontiers in immunology 2022;13:922195
Frontiers in immunology 2022;13:922195
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CD134/OX40 antibody from Proteintech is a rabbit polyclonal antibody to a peptide of human CD134/OX40. This antibody recognizes human antigen. The CD134/OX40 antibody has been validated for the following applications: ELISA, WB analysis.
